On optimizing therapies, Orai, and ORNs.
JGP. eadler@rockefeller.edu
Elizabeth M
EM
Adler
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D051638:Ether-A-Go-Go Potassium Channels / Q000235:genetics*; D006801:Humans; D008133:Long QT Syndrome / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D009154:Mutation / Q000235:genetics*; D062554:NAV1.5 Voltage-Gated Sodium Channel / Q000235:genetics*; D039904:Pluripotent Stem Cells / Q000502:physiology*
D000889:Anti-Arrhythmia Agents; D051638:Ether-A-Go-Go Potassium Channels; D062554:NAV1.5 Voltage-Gated Sodium Channel